Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Politics Aside

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Nov 05, 2021 12:13pm

413 Views

Post# 34092485

RE:Politics Aside

I'm hoping we can get 3 out the next 6 CR or better. ( even 2 out of 6 would be decent). That would make it 7 out of 12 patients who got optimized treatment in PH2 or 9 out of 14 if we include the 2 from PH1 who also get an optimized treatment. We would be beating competition at 3 months data and with only one single treatment Vs many many more. Of course anything better and we start to make the competition look real bad. All IMo

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December